Broncho-vaxom therapy for children with chronic bronchitis

Area of Science:

• Pediatrics
• Immunology
• Respiratory Medicine

Background:

• Chronic bronchitis in children presents a significant health burden.
• Recurrent respiratory infections necessitate effective therapeutic interventions.
• Evaluating immunomodulatory agents for pediatric respiratory conditions is crucial.

Purpose of the Study:

• To assess the efficacy of Broncho-Vaxom in managing chronic bronchitis in pediatric patients.
• To determine the impact of Broncho-Vaxom on the frequency and severity of acute respiratory episodes.
• To evaluate the effect of Broncho-Vaxom on antibiotic usage in children with chronic bronchitis.

Main Methods:

• A clinical study was conducted between 1985 and 1986.
• The study involved pediatric patients diagnosed with chronic bronchitis.
• Efficacy was evaluated based on observed reductions in acute episodes and antibiotic use during Broncho-Vaxom therapy.

Main Results:

• Broncho-Vaxom therapy demonstrated a significant reduction in the number of acute episodes.
• A notable decrease in the severity of acute respiratory episodes was observed.
• The study recorded a significant reduction in the need for antibiotic treatment.

Conclusions:

• Broncho-Vaxom is effective in reducing acute episodes in children with chronic bronchitis.
• The therapy leads to a decreased reliance on antibiotics for managing these conditions.
• Broncho-Vaxom is recommended for the treatment of chronic and recurrent respiratory infections in children.